NYSE · CIK 0000059478
LLY ELI LILLY & Co
Insider trading from SEC Form 4. Last filing Mar 19, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
15
with a Form 4 at this company
Signals
Open-market buys and sells at ELI LILLY & Co, scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 21Weak | sell10b5-1 | Zakrowski Donald A SVP, Finance, & CAO | $723k | 900 | -14% | - |
Congressional trades
68 trades in LLY disclosed by members of Congress under the STOCK Act, the newest 20 shown. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| John Boozman Senate · R-AR | Partial sale | LLY Eli Lilly and Company | $1,001 to $15k | Nov 21, 2025 | 276 days after the trade |
| Michael A. Rulli House · R-OH | Sale | LLY Eli Lilly and Company Common Stock | $1,001 to $15k | Dec 2, 2025 | 248 days after the trade |
| Michael A. Rulli House · R-OH | Sale | LLY Eli Lilly and Company Common Stock | $1,001 to $15k | Jul 1, 2026 | 37 days after the trade |
| Michael A. Rulli House · R-OH | Purchase | LLY Eli Lilly and Company Common Stock | $1,001 to $15k | Jan 2, 2026 | 217 days after the trade |
| Tommy Tuberville Senate · R-AL | Sale | LLY Eli Lilly and Company | $15k to $50k | Apr 15, 2025 | 477 days after the trade |
| Alan Armstrong Senate · R-OK | Sale | LLY Eli Lilly and Company Common Stock | $1,001 to $15k | Mar 27, 2026 | 116 days after the trade |
| Dan Newhouse House · R-WA | Partial sale | LLY Eli Lilly and Company Common Stock | $1,001 to $15k | Jul 10, 2026 | 7 days after the trade |
| Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | LLY Eli Lilly and Company Common Stock | $50k to $100k | Jun 10, 2026 | 22 days after the trade |
| Byron Donalds House · R-FL | Purchase | LLY Eli Lilly and Company Common Stock | $1,001 to $15k | Apr 2, 2026 | 41 days after the trade |
| Byron Donalds House · R-FL | Purchase | LLY Eli Lilly and Company Common Stock | $1,001 to $15k | Apr 2, 2026 | 41 days after the trade |
| Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | LLY Eli Lilly and Company Common Stock | $1,001 to $15k | Apr 14, 2026 | 24 days after the trade |
| Lizzie Fletcher House · D-TX | Partial sale | LLY Eli Lilly and Company Common Stock | $1,001 to $15k | Apr 8, 2026 | 23 days after the trade |
| Gilbert Ray Cisneros, Jr. House · D-CA | Partial sale | LLY Eli Lilly and Company Common Stock | $1,001 to $15k | Mar 13, 2026 | 25 days after the trade |
| Angus S. King, Jr. Senate · I-ME | Sale | LLY Eli Lilly and Company Common Stock | $1,001 to $15k | Feb 13, 2026 | 39 days after the trade |
| David J. Taylor House · R-OH | Purchase | LLY Eli Lilly and Company Common Stock | $1,001 to $15k | Feb 26, 2026 | 8 days after the trade |
| David J. Taylor House · R-OH | Sale | LLY Eli Lilly and Company Common Stock | $1,001 to $15k | Feb 9, 2026 | 11 days after the trade |
| David J. Taylor House · R-OH | Sale | LLY Eli Lilly and Company Common Stock | $1,001 to $15k | Jan 16, 2026 | 17 days after the trade |
| Angus S. King, Jr. Senate · I-ME | Purchase | LLY Eli Lilly and Company | $1,001 to $15k | Dec 29, 2025 | 28 days after the trade |
| Markwayne Mullin Senate · R-OK | Purchase | LLY Eli Lilly and Company Common Stock | $15k to $50k | Dec 29, 2025 | 18 days after the trade |
| Julie Johnson House · D-TX | Sale | LLY Eli Lilly and Company Common Stock | $1,001 to $15k | Dec 18, 2025 | 28 days after the trade |
Transactions
The last 39 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 17, 2025 | Alvarez Ralph director | AGrant or award Common Stock | +14 | $824.76 | $12k | 54,833 | Mar 19, 2025 |
| Feb 18, 2025 | Alvarez Ralph director | AGrant or award Common Stock | +14 | $857.20 | $12k | 54,719 | Feb 19, 2025 |
| Jan 21, 2025 | Alvarez Ralph director | AGrant or award Common Stock | +16 | $742.35 | $12k | 54,705 | Jan 23, 2025 |
| Dec 16, 2024 | Alvarez Ralph director | AGrant or award Common Stock | +15 | $779.00 | $12k | 54,689 | Dec 17, 2024 |
| Dec 16, 2024 | Hedley Mary Lynne director | AGrant or award Common Stock | +13 | $779.00 | $9,917 | 1,879 | Dec 17, 2024 |
| Dec 16, 2024 | JOHNSON KIMBERLY H director | AGrant or award Common Stock | +12 | $779.00 | $9,667 | 3,032 | Dec 17, 2024 |
| Dec 16, 2024 | LUCIANO JUAN R director | AGrant or award Common Stock | +19 | $779.00 | $15k | 16,191 | Dec 17, 2024 |
| Dec 16, 2024 | Sulzberger Gabrielle director | AGrant or award Common Stock | +13 | $779.00 | $9,917 | 2,533 | Dec 17, 2024 |
| Nov 18, 2024 | Fyrwald J Erik director | AGrant or award Common Stock | +321 | $727.20 | $233k | 72,541 | Nov 20, 2024 |
| Nov 18, 2024 | LUCIANO JUAN R director | AGrant or award Common Stock | +20 | $727.20 | $15k | 15,844 | Nov 20, 2024 |
| Nov 18, 2024 | Kaelin William G Jr director | AGrant or award Common Stock | +303 | $727.20 | $220k | 21,465 | Nov 20, 2024 |
| Nov 18, 2024 | Sulzberger Gabrielle director | AGrant or award Common Stock | +14 | $727.20 | $9,917 | 2,214 | Nov 20, 2024 |
| Nov 18, 2024 | JOHNSON KIMBERLY H director | AGrant or award Common Stock | +13 | $727.20 | $9,667 | 2,713 | Nov 20, 2024 |
| Nov 18, 2024 | JACKSON JAMERE director | AGrant or award Common Stock | +303 | $727.20 | $220k | 9,154 | Nov 20, 2024 |
| Nov 18, 2024 | Hedley Mary Lynne director | AGrant or award Common Stock | +14 | $727.20 | $9,917 | 1,562 | Nov 20, 2024 |
| Nov 18, 2024 | Baicker Katherine director | AGrant or award Common Stock | +303 | $727.20 | $220k | 23,118 | Nov 20, 2024 |
| Nov 18, 2024 | Walker Karen director | AGrant or award Common Stock | +303 | $727.20 | $220k | 6,249 | Nov 20, 2024 |
| Nov 18, 2024 | Alvarez Ralph director | AGrant or award Common Stock | +16 | $727.20 | $12k | 54,284 | Nov 20, 2024 |
| Nov 18, 2024 | Sulzberger Gabrielle director | AGrant or award Common Stock | +303 | $727.20 | $220k | 2,517 | Nov 20, 2024 |
| Nov 18, 2024 | LUCIANO JUAN R director | AGrant or award Common Stock | +303 | $727.20 | $220k | 16,147 | Nov 20, 2024 |
| Nov 18, 2024 | Hedley Mary Lynne director | AGrant or award Common Stock | +303 | $727.20 | $220k | 1,864 | Nov 20, 2024 |
| Nov 18, 2024 | Alvarez Ralph director | AGrant or award Common Stock | +303 | $727.20 | $220k | 54,586 | Nov 20, 2024 |
| Nov 18, 2024 | JOHNSON KIMBERLY H director | AGrant or award Common Stock | +303 | $727.20 | $220k | 3,015 | Nov 20, 2024 |
| Nov 8, 2024 | Zakrowski Donald A SVP, Finance, & CAO | SOpen-market sale Common Stock10b5-1 | -900 | $803.38 | $723k | 5,480 | Nov 8, 2024 |
| Nov 1, 2024 | Dozier Eric EVP, HR & Diversity | MOption exercise Common Stock | +1,534 | $0.00 | $0 | 8,724 | Nov 5, 2024 |
| Nov 1, 2024 | Hernandez Edgardo EVP & Pres., Mfg. Operations | MOption exercise Common Stock | +1,687 | $0.00 | $0 | 31,369 | Nov 5, 2024 |
| Nov 1, 2024 | Montarce Lucas EVP & CFO | MOption exercise Common Stock | +1,074 | $0.00 | $0 | 11,541 | Nov 5, 2024 |
| Nov 1, 2024 | Dozier Eric EVP, HR & Diversity | FTax withholding Common Stock | -681 | $818.93 | $558k | 8,043 | Nov 5, 2024 |
| Nov 1, 2024 | Hernandez Edgardo EVP & Pres., Mfg. Operations | FTax withholding Common Stock | -751 | $818.93 | $615k | 30,618 | Nov 5, 2024 |
| Nov 1, 2024 | Montarce Lucas EVP & CFO | FTax withholding Common Stock | -467 | $818.93 | $383k | 11,074 | Nov 5, 2024 |
| Nov 1, 2024 | Montarce Lucas EVP & CFO | MOption exercise Restricted Stock Unitderivative | -1,074 | $0.00 | $0 | 0 | Nov 5, 2024 |
| Nov 1, 2024 | Hernandez Edgardo EVP & Pres., Mfg. Operations | MOption exercise Restricted Stock Unitderivative | -1,687 | $0.00 | $0 | 0 | Nov 5, 2024 |
| Nov 1, 2024 | Dozier Eric EVP, HR & Diversity | MOption exercise Restricted Stock Unitderivative | -1,534 | $0.00 | $0 | 0 | Nov 5, 2024 |
| Oct 31, 2024 | Van Naarden Jacob EVP & Pres., Lilly Oncology | GGift Common Stock | -4,302 | $0.00 | $0 | 11,845 | Nov 1, 2024 |
| Oct 21, 2024 | Alvarez Ralph director | AGrant or award Common Stock | +13 | $906.13 | $12k | 54,267 | Oct 22, 2024 |
| Oct 21, 2024 | Hedley Mary Lynne director | AGrant or award Common Stock | +11 | $906.13 | $9,967 | 1,548 | Oct 22, 2024 |
| Oct 21, 2024 | JOHNSON KIMBERLY H director | AGrant or award Common Stock | +11 | $906.13 | $9,967 | 2,699 | Oct 22, 2024 |
| Oct 21, 2024 | LUCIANO JUAN R director | AGrant or award Common Stock | +16 | $906.13 | $14k | 15,825 | Oct 22, 2024 |
| Oct 21, 2024 | Sulzberger Gabrielle director | AGrant or award Common Stock | +11 | $906.13 | $9,967 | 2,201 | Oct 22, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Alvarez Ralphdirector
- Baicker Katherinedirector
- Dozier EricEVP, HR & Diversity
- Fyrwald J Erikdirector
- Hedley Mary Lynnedirector
- Hernandez EdgardoEVP & Pres., Mfg. Operations
- JACKSON JAMEREcfo, officer, director
- JOHNSON KIMBERLY Hdirector, coo, officer
- Kaelin William G Jrdirector
- LUCIANO JUAN Rdirector, ceo, president, officer
- Montarce LucasEVP & CFO
- Sulzberger Gabrielledirector
- Van Naarden JacobEVP & Pres., Lilly Oncology
- Walker Karendirector
- Zakrowski Donald ASVP, Finance, & CAO
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.